Background Instead of scaling glomerular filtration rate (GFR) to a body surface area of 1.73 m 2 , it has been suggested to scale GFR to extracellular fluid volume (ECV).
Introduction
The glomerular filtration rate (GFR) is the most widely used single parameter for assessing renal function. Most often, GFR is expressed in relation to a standard body surface area (BSA) of 1.73 m 2 . The normalization to BSA has long historical roots [1] but has no physiological explanation and may, for instance, underestimate renal function in very obese individuals [2] .
As an alternative, it has been suggested to scale GFR to extracellular fluid volume (ECV) [3, 4] . Unlike surfacenormalized GFR, the ratio GFR/ECV (or the reverse ratio ECV/GFR) has a direct physiological interpretation. As expressed in Brøchner-Mortensen [3] :
These easily determined ratios indicate how often 'that which is to be regulated' (i.e. the extracellular fluids) comes into contact with 'the regulator' (i.e. the kidney).
A common technique for GFR determination is bolus injection of a GFR marker ( 51 Cr-EDTA, 99m Tc-DTPA, or iohexol), followed by the taking of two or more blood samples 3-4 h after the injection. However, it is much less commonly recognized that ECV and the ratio GFR/ ECV can be determined from the same data.
Brøchner-Mortensen [3] described how ECV could be calculated from the slope and intercept of the final part of the plasma concentration curve. The ratio GFR/ECV can be calculated afterwards. Interestingly, his data indicated that the precision of the ratio was in fact better than the precision of ECV alone. Peters [4, 5] determined the ratio of GFR/ECV directly from the slope.
The aim of the present study is three-fold: (i) to evaluate the approaches of Peters and of Brøchner-Mortensen; (ii) to develop a new simple and accurate formula for determination of ECV and thereby the ratio GFR/ECV; and (iii) to evaluate and compare these approaches.
Materials and methods

Overview of calculations
Clearance of 51 Cr-EDTA determined from the full plasma curve was used as the reference value for the glomerular filtration rate, GFR ref . (This choice is further discussed in the Discussion section.) Similarly, the distribution volume for 51 Cr-EDTA was used as the reference value for the extracellular fluid volume, ECV ref . Symbols and methods have been summarized in Tables 1 and 2 . Details are found in the Calculations section.
For all the methods tested, differences from reference values were computed as follows:
Absolute difference¼Method valueÀReference value;
Relative difference¼
Absolute difference Reference value Â100 % :
Bias and SD were computed corresponding to the mean and SD of the relative differences (for details, see the Calculations section).
Participants investigated
The present study comprised a total of 128 individuals (35 women, 66 men and 27 children), all of whom had a complete plasma concentration curve determined after an intravenous bolus injection of 51 Cr-EDTA. None had oedema, and they were chosen from three previously published studies: Study I [3] -68 nephro-urological patients and 17 normal individuals; Study II [7] -16 patients with type 1 diabetes investigated during periods of moderate hyperglycaemia; Study III [8] -27 children aged up to 12 years, all suffering from a nephro-urological disorder.
The data pertaining to the investigated individuals are given in Table 3 . In the table, the ratio GFR/ECV is expressed in unit %/h; for example, for a person with GFR = 90 ml/min and ECV = 12 l 90 ml= min 12 000 ml ¼0:0075=min¼0:45=h¼45 % =h:
Procedure
The individuals were confined to bed throughout the examination, which lasted for 4-5 h.
51
Cr-EDTA of 2-4 MBq and a known amount of T 1824 (Evans blue) were injected intravenously through the membrane of an indwelling needle with simultaneous injection of 10 ml of isotonic saline. In Study III, the activity of 51 Cr-EDTA was reduced to about 0.1 MBq/kg of body weight. Venous blood samples were drawn through an indwelling needle in the contralateral arm. In Study I, the blood samples were taken at time intervals of 15-30 min for 4-5 h. In Study II and Study III, the blood samples were taken 5, 10, 15, 30, 60, 90, 120, 150, 180, 200, 220 and 240 min after the injection, supplemented with a blood sample at 300 min in children with known severely reduced renal function. All blood samples were counted in a well-type counter to 10 000 counts.
The plasma volume was determined using T 1824 (Evans blue) (see [9] for details on the method). Activity of 51 Cr-EDTA at time zero was calculated as the ratio between the injected amount of tracer and plasma volume.
Calculations Determination of reference GFR
For determination of reference parameters, the measured plasma concentration curve was resolved into a sum Denoted as B by Peters, see the note above. of two to four monoexponential functions:
In line with the notation in Brøchner-Mortensen and colleagues [3, 6, 9] , the numbering of the exponentials was chosen so that b 1 < b 2 < ?, giving a convenient notation, wherein the slowest, most important exponential has number 1, regardless of the number of exponentials involved in the full plasma concentration curve.
The intercept c 1 and the rate constant b 1 of the slowest exponential were calculated by the least-squares fit to the plasma samples drawn 3-4 h after the injection (3-5 h in cases in which a 5 h sample was taken). The remaining exponentials in the full plasma concentration curve were then resolved with a standard peeling-off technique. For about half of the patients in Study I, a total of two exponentials were used, and for all others three or four exponentials were used.
The total plasma clearance (Cl) was determined as the ratio between the injected amount of tracer (Q 0 ), and the area under the plasma concentration curve:
In the present study, these clearance values based on the full 51 Cr-EDTA concentration curve were used as references values for the glomerular filtration rate, GFR ref = Cl EDTA .
Calculation of GFR from one-pool (slope-intercept) clearance
In clinical practice, the full plasma concentration curve is seldom known. However, if at least two blood samples are taken at time points that are so late that only one exponential is left in the plasma concentration curve, then the slope b 1 and intercept c 1 of this final, slowest exponential can be determined. On the basis of this single exponential, a 'one-pool' clearance (also called a slope-intercept clearance or a final-slope clearance) can be calculated:
As Q 0 is divided by an area that is smaller than the full area, Cl 1 will always be higher than the true Cl and must be corrected.
In the present study, we used the following correction formula [6] :
where
and BSA is the body surface area in m 2 . This correction formula is applicable to individuals of all sizes (from small children to very obese adults) and at all levels of renal function, including the very high renal functions at which quadratic corrections fail [6, 10] , and has been validated in an independent study [11] .
Determination of reference ECV
The distribution volume of 51 Cr-EDTA is often taken to be equal to the ECV [3, 12] . Therefore, in this study we have used ECV synonymously with distribution volume.
From the general tracer-kinetic theory, the distribution volume is related to clearance as follows:
where t is the mean transit time for the tracer: t¼
Thus,
These ECV values calculated from the full curve were used as reference values for the extracellular fluid volume, ECV ref .
Approximate ECV from one-pool (slope-intercept) data
An approximation V 1 to the distribution volume can be calculated using only one exponential (i.e. the slowest exponential):
Note also that
and is the mean transit time corresponding to the slowest exponential. Accordingly, the resulting time is longer than the mean transit time based on the full curve, that is, t 1 > t, and it follows that V 1 > ECV.
The Peters method for GFR/ECV and ECV determination from one-pool data
Peters [4] advocated describing the renal function in terms of GFR divided by ECV, a ratio that can be approximated simply as the rate constant of the slowest exponential:
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This rate constant has been suggested by Peters et al. [13] as a measure of renal function. In the present context, we denote this as a simple estimate of GFR/ECV:
However, as noted above, t 1 overestimates the true mean transit time t. Peters et al. [5] therefore multiplied the rate constant by 1 plus a proportional term. In our notation:
where m is a constant value. In the cited study [5] , Peters and colleagues found the value m = 15.4 min = 0.0154 (ml/min/l) -1 for EDTA. Bird et al. [12] has validated the correction using this value of the constant.
In the present study, Peters' method was evaluated by plotting GFR ref /ECV ref as a function of b 1 to confirm whether the points did lie on a well-defined curve of the form described by Eq. (14) and whether the constant m = 15.4 min could be confirmed.
ECV can also be of interest in itself. As Peters' formula [Eq. (14) ] expresses ECV only in combination with GFR, we calculated a 'Peters' value for ECV with the help of GFR JBM :
The Brøchner-Mortensen equation for ECV and GFR/ECV determination from one-pool data Brøchner-Mortensen [3] calculated ECV as follows:
This can also be seen as a correction to the simple onepool value V 1 :
Equations (16) and (17) are mathematically equivalent.
In the present study, the form of this correction was evaluated in the following way. On the basis of the reference values for Cl (GFR) and ECV, the ratio V 1 /ECV was plotted as a function of the ratio Cl 1 /Cl. The former ratio is the factor by which the one-pool volume (V 1 ) overestimates the true volume (ECV), whereas the latter ratio is the similar overestimation factor for clearance. In such a plot, Brøchner-Mortensen's ECV equation gives a well-defined curve: for a given value of x = Cl 1 /Cl, the value of y = V 1 /ECV BM can be calculated from Eq. (17).
The resulting plot compares Brøchner-Mortensen's equation [i.e. Eqs (16) and (17)] with the 'true' relation between V 1 /ECV and Cl 1 /Cl from the reference data.
Brøchner-Mortensen's equation is meant to be used in cases in which only one-pool data are known. Thus, Cl must be determined from Cl 1 . In the original study [3] , a variant of Brøchner-Mortensen's classical clearance correction [9] was used, and the study included only adults. Here, we used instead Cl JBM , that is, the improved correction defined by Eqs (4) and (5), and included both adults and children.
We also calculated a corresponding 'Brøchner-Mortensen' estimate of GFR/ECV:
A new, simple method for ECV and GFR/ECV determination from one-pool data
The present study revealed the following simple relation:
This new relation can also be expressed as follows:
that is, V 1 overestimates ECV twice as much as Cl 1 overestimates Cl (e.g. if Cl 1 is 20% higher than Cl, then V 1 is 40% higher than ECV). A theoretical basis for this finding is given in Appendix 1, along with an analysis of its degree of accuracy.
Using Cl JBM from Eq. (4), we can calculate the relative overestimation of clearance by Cl 1 as follows:
leading to a new formula for the relative overestimation of ECV and thereby a new formula for calculation of ECV from V 1 :
where f is the factor given by Eq. (5).
The ratio GFR/ECV was estimated for this new method as well: 
Results
Test of equations using reference values 
Comparison of methods when applied to one-pool values
Four methods were compared with reference values for ECV and GFR/ECV:
(1) the simple (slope-only) method for GFR/ECV and the simple V 1 estimate for ECV [see Eqs (13) and (9), respectively]; (2) Peters' method [see Eqs (14) and (15) 
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ECV
The differences between estimated and reference ECV values were found to be normally distributed for each method if adults and children were considered separately and data were logarithmized. The F-test for each method showed SD 2 to differ between adults and children (P = 0.03 for the simple V 1 method; P r 0.0001 for the other three methods). Bias, SD and LOA were calculated on logarithmic values but are reported as percentage deviations from reference values -for example, bias% = (exp(bias ln ) -1) Â 100%. Figure 3 shows Bland-Altman plots for relative differences between estimated and reference ECV. The corresponding results for bias and SD are given in Table 4 . For adults, all methods had statistically significant bias (P < 0.03), whereas for children bias was only significant for the simple V 1 method.
Levene's test showed a significant difference between variances for adults (P < 0.0001) but not for children (P = 0.2). For adults, the pairwise comparisons showed SD 2 to be significantly higher for the simple V 1 method than for any other method (P < 0.0001), whereas SD 2 did not differ between any of the other three methods (P > 0.3 in these comparisons).
GFR/ECV
Likewise, for GFR/ECV it was found that separation of adults and children and logarithmization of data gave the best results in the normality test; for the logarithmized data, only Peters' method showed signs of non-normality (adults only, P = 0.04). We proceeded using the F-test, bearing in mind that the conclusions should be tentative in the case of Peters' method for GFR/ECV. For all methods, except the simple b 1 method, variance (SD 2 ) was significantly higher for children than for adults (P = 0.07 for the simple method; P r 0.004 for the other three methods). Figure 4 and Table 5 show results for GFR/ECV for the four methods. For adults, bias was statistically significant for all methods (P r 0.0003), whereas in children this was the case only for the simple method and Peters' method (P r 0.0006 for these methods, P > 0.3 for BM and JBM).
Levene's test showed SD 2 to differ significantly between methods for adults (P < 0.0001) but not for children (P = 0.2). The pairwise F-tests for adults showed the simple b 1 rate constant to have larger SD 2 compared with Peters' method (P < 0.001), which had higher SD 2 than both the BM and JBM methods (P r 0.004). Variance of BM and JBM did not differ significantly (P = 0.9).
Discussion
The clinical role of ECV and GFR/ECV
The kidneys play a key role in the regulation of body fluids and elimination of waste products. Renal function can be expressed as GFR in ml/min, a number that is often scaled to BSA, expressing GFR in ml/min/1.73 m 2 . This scaling has been empirically proven to be useful because standard materials show normal values of GFR in ml/min/1.73 m 2 to be relatively independent of age from children above the age of 2 [16] up to adults aged 40-50 years, after which it decreases at a rate of 9-10 ml/min/1.73 m 2 per decade [17, 18] . However, apart from the general expectation that a larger body needs larger filtering, there is no physiological reason why renal function should be coupled with BSA. Furthermore, the result will depend on the choice and accuracy of the formula used for calculation of BSA [2] .
In contrast, scaling GFR to ECV has a direct physiological interpretation: it links the regulation rate (GFR) to the amount of fluid to be regulated (ECV). Expressing GFR/ ECV in the unit %/h can help give an intuitive understanding of the number. For example, 45%/h (as in the earlier example) means that the volume of plasma filtered by the kidneys in 1 h corresponds to 45% of the total volume involved (ECV). A useful unit conversion is 1 ml/min/ l = 6%/h. It is of course also possible to express GFR/ECV as scaled to a 'standard ECV'. If, for instance, 12 l is used as 'standard ECV', we find 50%/h = 100 ml/min/12 l.
We have studied simplified methods for the determination of GFR/ECV after an intravenous bolus injection of 51 Cr-EDTA on the basis of two different approaches: either from the rate constant b 1 of the final exponential (the simple method and Peters' method) or from the ratio between one-pool clearance and total plasma clearance (Brøchner-Mortensen's method and the new JBM method).
Correctness of methods based on b 1 (simple and Peters) As described previously, the ratio GFR/ECV = Cl/ECV can be calculated using the rate constant b 1 as a first approximation, followed by a correction, again based only on b 1 . The underlying assumption in such a method is that GFR/ECV is a well-defined function of b 1 .
As seen by the 'true' values in Fig. 1 , the ratio GFR/ECV can be reasonably well described as a function of b 1 (GFR/ ECV = b 1 + mb 1 2 ), although GFR/ECV is slightly underestimated at high levels of b 1 (high renal function) when the original value of m = 15.4 min is used (Peters et al. [5] and Bird et al. [12] ). The current data point to a more reliable value of mE20 min.
This altered value of the constant is in fact in line with a study by Bird et al. [19] . Table I of that study gives  for 51 Cr-EDTA a correction that, in our notation, is 0.965b 1 + 0.00204b 1 2 (ml/min/l) -1 = 0.965b 1 + 20.4b 1 (min). However, in the later study [12] , the original version of the correction was used: that is, m = 15.4 min = 0.0154 (ml/min/l) -1 .
Correctness of methods based on Cl 1 /Cl (BM and JBM)
This principle is based on the relationship between V 1 /ECV and Cl 1 /Cl. Using the BM method for determination of ECV [3] [i.e. Eq. (16) or (17)] on the basis of reference values, it was shown that there is indeed a welldefined relationship between y = V 1 /ECV and x = Cl 1 /Cl (Fig. 2) , although with the BM method V 1 /ECV is underestimated to some extent at high renal function leading to a minor overestimation of ECV and a corresponding underestimation of GFR/ECV.
As an unexpectedly simple result, we found the data in Fig. 2 to be very close to the line y = 2x -1 (dashed line). In retrospect, such a relation might have been expected from the study by Peters et al. [5] . In an appendix, they argued that the gradient of an equation for V 1 /ECV would be approximately twice the gradient of an equation for Cl 1 /Cl. However, the authors did not analyse this result further, nor did they evaluate the extent to which it would be correct for different values of renal function. In Appendix 1 of the present study, the relationship has been analysed, and it has been argued that the relationship can be expected to be fairly accurate for all levels of renal function. The equation for the resulting ECV estimate, ECV JBM , is given in Eq. (24).
Comparison of the methods for clinical use
All the methods have been developed for use in clinical situations in which only the injected amount of activity and one-pool data (i.e. the final exponential of the plasma concentration curve) are known.
Results for ECV (Fig. 3 and Table 4) show that the simple V 1 method yields poor results with respect to both bias and spread. Although the other three methods have a statistically significant bias, a small percentage of bias is not important from a clinical point of view and will drown in the spread for the individual patient (as indicated by the 95% LOA). The larger spread for children than for adults can be explained by the findings in Jødal and Brøchner-Mortensen [6] that the area under the fast exponential(s) has a larger variation in children than in adults.
For GFR/ECV (Fig. 4 and Table 5 ), the simple rate constant method might be used if one is aware that especially high values (Fig. 4) will have bias compared with the 'true' GFR/ECV and that the method has a rather large spread. The dependence on renal function means that any single number for 'bias' of the simple rate constant method will depend on the population, and the number in Table 5 for this method should be considered only as an example.
With regard to the spread of GFR/ECV, the BM and JBM methods had especially favourable results. Rounding the numbers, the 95% LOA were from -4% to + 7% for adults and ±9% for children. These are very narrow limits for clinical data and at least as good as the corresponding LOA for clearance (and thereby GFR) found in Jødal and Brøchner-Mortensen [6] . Largely on the basis of the same data as in the present study, Jødal and Brøchner-Mortensen found that 95% LOA for clearance were (in round numbers) ±7% for adults and from -11% to + 13% for children. The narrow LOA for GFR JBM / ECV JBM is because of the variable f being present in both the numerator and the denominator, giving the effect that estimation errors in f to some extent cancel out.
JBM versus BM: As seen by the curves in Fig. 2 , the JBM and BM methods will in most, but not all, cases give very similar results. The value on the horizontal axis is x = Cl 1 / Cl = 1 + f Â Cl 1 , using the JBM formulation [Eq. (4)]; hence, the differences are seen when either f or Cl 1 or both have high values. The factor f is high for small subjects [Eq. (5)], whereas one-pool clearance Cl 1 is high when renal function is high. Thus, the new JBM method for calculation of ECV and GFR/ECV will be more accurate than the BM method in individuals with high renal function, especially in children. As the present study included only a few patients with these characteristics, this higher accuracy was not reflected in the overall bias and SD but is clearly seen in the rightmost part of Fig. 2. same for moderately reduced renal function, and 5-10% higher for normal and high renal function. However, when measured in percentage, as here, the spread and bias are virtually unaffected (data not shown).
Conclusion
GFR/ECV is a physiologically relevant measure of renal function and can be determined with good precision. We found the best precision using GFR determined by the method of Jødal and Brøchner-Mortensen [Eqs (4) and (5) The formula for GFR/ECV presented by Peters [5] [Eq. (14) ] gives reasonably precise values, but with the factor 15.4 min the method underestimates GFR/ECV at high renal function, according to our data.
The new JBM method for determination of ECV was theoretically more correct than the BM method. In practice, the difference is very small for most patients but will be seen in patients (especially children) with high renal function.
Expressing renal function as the ratio GFR/ECV gives a physiologically relevant measure of the renal function, which can be determined with at least as high precision as when using GFR. This can be an important supplement to the usual scaling of GFR to BSA of 1.73 m 2 , but normal ranges will need to be established. : ðA5Þ
The approximate values for Z and b correspond to using no more than two exponentials in the plasma concentration curve, ignoring exponentials faster than those. The approximations are used here only to see that Z 2 and b are both second-order values in terms of b 1 /b 2 , a ratio that by definition is less than 1. Thus, expressing Eq. (A3) to first order we find:
in accordance with the empirical relation given by Eq. (20) .
It is worth considering the accuracy of Eq. (A6) compared with the exact Eq. (A3). As the ignored terms Z 2 and b are coupled with the corrections for Cl 1 and V 1 , the approximation will be good when the corrections are small, which will be the case for low renal function. But what happens for high renal function? In the present study, both Z 2 and b had a median value of 0.02 but maximum values of 0.13 and 0.26, respectively. First, it should be noted that both the numerator and denominator of Eq. (A3) have a positive term ignored by the approximation in Eq. (A6). Therefore, the errors above and below the fraction line will to some extent cancel each other, giving a result that is more accurate than the individual approximations. Second, the ignored terms are correlated, as seen by Eqs (A4) and (A5): Z 2 E(c 2 /c 1 )b. This means that the approximation errors in the numerator and denominator will grow together, thereby keeping a relatively high accuracy for Eq. (A6) even when corrections are large.
In conclusion, the empirical relation in Eq. (20) has been given a theoretical explanation, and the relation is expected to be relatively accurate for all levels of renal function. This expectation is in line with the data shown in Fig. 2 .
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